Key result
Symptom-level 30-day risk-standardized mortality rates can be feasibly calculated for chest pain presentations using routine data, yielding a highly discriminative model.
Why the study?
Procedural and disease-based risk-standardized mortality rates can promote risk-averse decisions and miss the full patient journey; whether symptom-level rates feasibly monitor hospital performance using routinely collected linked data was unknown.
Is it feasible to use symptom-level risk-standardized mortality rates (RSMR) to monitor hospital performance for acute chest pain presentations?
Observational (n=192,978)
Yes
Is it feasible to use symptom-level risk-standardized mortality rates (RSMR) to monitor hospital performance for acute chest pain presentations?
Symptom-level 30-day risk-standardized mortality rates can be feasibly calculated using routine data to monitor hospital performance for chest pain presentations, providing additional insights beyond existing process measures.
Answers are grounded in this paper and cite their sources.
May support symptom-level outcome monitoring for chest pain; leaves open validation and impact on performance assessment.
AIMS: Risk-standardized mortality rates (RSMR) have been used to monitor hospital performance in procedural and disease-based registries, but limitations include the potential to promote risk-averse clinician decisions and a lack of assessment of the whole patient journey. We aimed to determine whether it is feasible to use RSMR at the symptom-level to monitor hospital performance using routinely collected, linked, clinical and administrative data of chest pain presentations. METHODS AND RESULTS: We included 192 978 consecutive adult patients (mean age 62 years; 51% female) with acute chest pain without ST-elevation brought via emergency medical services (EMS) to 53 emergency departments in Victoria, Australia (1/1/2015-30/6/2019). From 32 candidate variables, a risk-adjusted logistic regression model for 30-day mortality (C-statistic 0.899) was developed, with excellent calibration in the full cohort and with optimism-adjusted bootstrap internal validation. Annual 30-day RSMR was calculated by dividing each hospital's observed mortality by the expected mortality rate and multiplying it by the annual mean 30-day mortality rate. Hospital performance according to annual 30-day RSMR was lower for outer regional or remote locations and at hospitals without revascularisation capabilities. Hospital rates of angiography or transfer for patients diagnosed with non-ST elevation myocardial infarction (NSTEMI) correlated with annual 30-day RSMR, but no correlations were observed with other existing key performance indicators. CONCLUSION: Annual hospital 30-day RSMR can be feasibly calculated at the symptom-level using routinely collected, linked clinical, and administrative data. This outcome-based metric appears to provide additional information for monitoring hospital performance in comparison with existing process of care key performance measures.
No takes yet. Share an insight, caveat, or question.
Dawson et al. (2022) conducted an observational in Acute chest pain without ST-elevation (n=192,978). Symptom-level 30-day risk-standardized mortality rate (RSMR) was evaluated on 30-day mortality. Symptom-level 30-day risk-standardized mortality rates can be feasibly calculated for chest pain presentations using routine data, yielding a highly discriminative model.
Synapse has enriched 10 related papers. Consider them for comparative context: